Page last updated: 2024-10-24

protein O-linked glycosylation via threonine

Definition

Target type: biologicalprocess

The glycosylation of protein via the O3 atom of peptidyl-threonine, forming O3-glycosyl-L-threonine; the most common forms are N-acetylgalactosaminyl, mannosyl, and galactosyl threonine. [RESID:AA0155]

Protein O-linked glycosylation via threonine is a post-translational modification where a sugar molecule is attached to the hydroxyl group of a threonine residue in a protein. This process is distinct from N-linked glycosylation, which occurs on asparagine residues.

The process typically begins with the activation of a sugar molecule, often N-acetylglucosamine (GlcNAc), by a specific enzyme called a glycosyltransferase. The activated sugar molecule is then transferred to the hydroxyl group of threonine by another glycosyltransferase, forming an O-linked glycosidic bond. The specific glycosyltransferase involved in this process determines the type of sugar added.

After the initial glycosylation event, the O-linked glycan can be further modified by the addition of other sugars, resulting in complex oligosaccharide structures. These modifications are carried out by a variety of glycosyltransferases and glycosidases.

O-linked glycosylation via threonine plays a critical role in various cellular processes, including:

* **Protein folding and stability:** O-linked glycosylation can influence the conformation and stability of proteins, contributing to their proper function.
* **Cellular signaling:** O-linked glycans can act as recognition signals for various cellular receptors, influencing cellular signaling pathways.
* **Immune recognition:** O-linked glycosylation patterns on proteins can influence immune responses, affecting the interaction with immune cells.

Overall, O-linked glycosylation via threonine is a complex and essential process that adds significant diversity and functionality to proteins, impacting a wide range of biological activities.'
"

Proteins (5)

ProteinDefinitionTaxonomy
Polypeptide N-acetylgalactosaminyltransferase 6A polypeptide N-acetylgalactosaminyltransferase 6 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8NCL4]Homo sapiens (human)
Polypeptide N-acetylgalactosaminyltransferase 13A polypeptide N-acetylgalactosaminyltransferase 13 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8IUC8]Homo sapiens (human)
Polypeptide N-acetylgalactosaminyltransferase 3A polypeptide N-acetylgalactosaminyltransferase 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q14435]Homo sapiens (human)
Polypeptide N-acetylgalactosaminyltransferase 1A polypeptide N-acetylgalactosaminyltransferase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q10472]Homo sapiens (human)
Polypeptide N-acetylgalactosaminyltransferase 2A polypeptide N-acetylgalactosaminyltransferase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q10471]Homo sapiens (human)

Compounds (6)

CompoundDefinitionClassesRoles
gallic acidgallate : A trihydroxybenzoate that is the conjugate base of gallic acid.trihydroxybenzoic acidantineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite
pyrenepyrene : An ortho- and peri-fused polycyclic arene consisting of four fused benzene rings, resulting in a flat aromatic system.

pyrene: structure in Merck Index, 9th ed, #7746
ortho- and peri-fused polycyclic arenefluorescent probe;
persistent organic pollutant
ellagic acidcatechols;
cyclic ketone;
lactone;
organic heterotetracyclic compound;
polyphenol
antioxidant;
EC 1.14.18.1 (tyrosinase) inhibitor;
EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor;
EC 2.4.1.1 (glycogen phosphorylase) inhibitor;
EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor;
EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor;
EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
food additive;
fungal metabolite;
geroprotector;
plant metabolite;
skin lightening agent
urolithin burolithin B: has antiproliferative activity; structure in first sourcecoumarins
urolithin durolithin D: has antiproliferative activity; structure in first sourcehydroxycoumarin
3,3'-di-o-methylellagic acid3,3'-di-O-methylellagic acid: structure given in first source